Researchers compared outcomes of individuals who had a stem cell transplantation who were randomly assigned to receive obinutuzumab or placebo after their transplantation.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/obinutuzumab-cuts-chronic-gvhd-after-transplant-2026a1000eqr?src=rss
Author :
Publish date : 2026-05-07 12:32:00
Copyright for syndicated content belongs to the linked Source.
